Empowered Funds
ANVS icon

Empowered Funds’s Annovis Bio ANVS Stock Holding History

Empowered Funds’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$41.9K Buy
+33,014
New +$53.8K ﹤0.01% 2487

Other funds holding ANVS

Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
SG
Sherry Group Mountain Home, Arkansas $107M AUM 11.17% 1-Year Est. Return

Empowered Funds's ANVS Position: Q3 2026 in Review

Empowered Funds opened a new position in Annovis Bio (ANVS) in Q3 2026: 33,014 shares worth $41.9K. The stake represents ﹤0.01% of the portfolio and ranks #2487 among its holdings.

49 funds tracked by Wall St. Rank hold ANVS as of Q3 2026.

  • Empowered Funds held 33,014 shares of Annovis Bio worth $41.9K as of Q3 2026.
  • Annovis Bio was a new Empowered Funds position in Q3 2026.
  • Annovis Bio made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2487 holding.
  • 49 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.